Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05004337 · ClinicalTrials.gov registry record

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

A clinical trial of Trisomy 21 and Trisomy 18, sponsored by Natera.

Completed
Registry status
126
Enrollment target
20
Study locations

NCT05004337 is a study of Trisomy 21 and Trisomy 18 that has completed, run by Natera. The registered enrollment target is 126 participants, below the 842-participant average among 5 other Trisomy 21 trials with a reported enrollment target (85% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05004337, a study of Trisomy 21 and Trisomy 18, has completed, sponsored by Natera.

COMPLETED
Registry status
126 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to collect blood samples from women carrying a vanishing twin pregnancy to further develop Natera's non-invasive prenatal screening test to provide information about possible chromosomal conditions for the living twin

Conditions Studied

Trisomy 21 Trisomy 18 Trisomy 13 Vanishing Twin

Study Locations (20)

New York

  • NYU Long Island - Mineola
  • NYU Langone - New York
  • Icahn School of Medicine at Mount Sinai Hospital - New York
  • Columbia University - New York
  • Weill Cornell Medicine - New York
  • Montefiore Medical Center - The Bronx

California

  • Center for Fetal Medicine & Women's Ultrasound - Los Angeles
  • Stanford - Palo Alto

Michigan

  • University of Michigan - Ann Arbor
  • Beaumont - Royal Oak

New Jersey

  • Hackensack - Neptune City
  • St. Peter's University Hospital - New Brunswick

Pennsylvania

  • Lehigh Valley Health Network - Allentown
  • University of Pennsylvania - Philadelphia

Colorado

  • University of Colorado - Aurora

Connecticut

  • Yale - New Haven

Delaware

  • Christiana Care - Newark

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2021-07-22
Est. Completion 2023-11-29

Sponsor

Natera

27 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05004337

The ClinicalTrials.gov registry entry for NCT05004337 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 842-participant average among 5 other Trisomy 21 trials with a reported enrollment target (85% lower). The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Trisomy 21 appearing as the primary indexed condition, and to 0 interventions.

NCT05004337 reports 20 study locations spanning 11 distinct geographic areas - top geographies include New York, California, Michigan.

Frequently Asked Questions

What is clinical trial NCT05004337 about?

NCT05004337 is a clinical study titled "Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies". The purpose of this study is to collect blood samples from women carrying a vanishing twin pregnancy to further develop Natera's non-invasive prenatal screening test to provide information about possible chromosomal conditions for the living twin

What is the current status of trial NCT05004337?

This trial is currently completed. The enrollment target is 126 participants. The study started on 2021-07-22. Estimated completion is 2023-11-29.

What conditions does trial NCT05004337 study?

This clinical trial studies the following conditions: Trisomy 21, Trisomy 18, Trisomy 13, Vanishing Twin.

Who is sponsoring clinical trial NCT05004337?

This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05004337 being conducted?

This trial has 20 study locations across California, Colorado, Connecticut, Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Trisomy 21

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Trisomy 21

All registered trials for this condition

Trisomy 18

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.